Six Sigma: A novel approach to pharmaceutical industry
The statistical concept, six sigma is used to define problems systematically, provides tools to measure and influential factors and identifies the improvements that can be implemented easily. It is quality management tool which can be considered as a vision, a philosophy, a symbol, a metric, a goal, a methodology. It simply means a measure of quality that struggle for near perfection. It is a highly disciplined process that focuses on developing & deliveringNear perfect product & services It is based on three element Process improvement, Process.
Design/re-design and Process management. When we use this technique for a process then process variation reduced to 3.4 DPMO (Defects per million Opportunities).Six sigma is divided in two sub methods DMAIC (Define, Measure, Analyze, Improve and Control) is improvement system for existing processes that doesnt meet specification. DMADV (Define, Measure, Analyze, Design, Verify) is used to develop new processes at six sigma level.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).